← Back to Clinical Trials
Recruiting NCT07243873
Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study
Trial Parameters
Condition Lung Cancer
Sponsor Shanghai Pulmonary Hospital, Shanghai, China
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,000
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2025-12-01
Completion 2026-06-01
All Conditions
Interventions
PET-CT
Brief Summary
This study aims to synthesise PET data that preserves biological relevance and adds clinical value to the diagnosis and prognosis of lung cancer by establishing anatomical-to-metabolic mapping based on paired diagnostic CT and FDG-PET scans, thereby prospectively validating the clinical utility of the model.
Eligibility Criteria
Inclusion Criteria: 1. Patients with non-small cell lung cancer scheduled to undergo PET-CT and pathological examinations; 2. Voluntarily participate and sign an informed consent form; Exclusion Criteria: 1. History of other malignant tumours; 2. Image artefacts; 3. Without pathological diagnostic information; 4. Without paired CT and FDG-PET scan images.